NexHA Hyaluronate Sodium is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis. NexHA is a sodium hyaluronate injectable solution. Each ml of NexHA contains 10 mg hyaluronate sodium solution. NexHA Hyaluronate Sodium is for administration by IV injection. NexHA has been approved by the FDA as a generic equivalent to Legend® Hyaluronate Sodium.
NexHA is manufactured by bacterial fermentation, resulting in a low protein content. Because it originates from a microbial source, there is no potential for contamination with materials of animal origin. Pyrogen-free.